AEterna Zentaris Inc (NASDAQ:AEZS)

0.648
Delayed Data
As of Feb 27
 +0.0302 / +4.89%
Today’s Change
0.48
Today|||52-Week Range
1.54
+8.00%
Year-to-Date
No recent news for AEterna Zentaris Inc.

Today’s Trading

Previous close0.62
Today’s open0.61
Day’s range0.61 - 0.67
Volume1,147,527
Average volume (3 months)721,429
Market cap$37.5M
Dividend yield--
Data as of 4:00pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+43.26%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-81.66%
P/E ratio--
Price/Sales6.60
Price/Book1.72

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd+0.14+16.31%
--Protea Biosciences G...-0.08-12.14%
ABACAoxin Tianli Group I...-0.14-8.34%
IMUCImmunoCellular Thera...-0.02-3.13%
Data as of 4:03pm ET, 02/27/2015

Financials

Next reporting dateMarch 24, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$6.2M
Annual profit (last year)$6.8M
Net profit margin-441.13%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David A. Dodd
Chief Financial Officer &
Senior Vice President
Dennis Turpin
Corporate headquarters
Québec, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account